Semaglutide-related Side Effects Include Ischemic Stroke, Pulmonary Embolism, and Deep Vein Thrombosis
(Posted by Tom Lamb at Drug Injury Watch)
Wegovy, Rybelsus, and Ozempic are drugs with semaglutide as their active ingredient. Semaglutide is associated with a
Law Offices of Thomas J. Lamb, P.A.
Website:
https://www.drug-injury.com/
Law Offices of Thomas J. Lamb, P.A. Blogs
Blog Authors
Latest from Law Offices of Thomas J. Lamb, P.A.
Syfovre Retinal Vaso-occlusive Vasculitis Case Report Involving 78-year Old Woman With Vision Loss
By Tom Lamb
She Went to the Local ER With Loss of Vision 11 Days After Receiving an Intravitreal Syfovre (Pegcetacoplan) Injection
(Posted by Tom Lamb at Drug Injury Watch)
In the March 2024 edition of the American Journal of…
Syfovre Eye Injury Cases: More Questions Than Answers One Year After First Reports
By Tom Lamb
Retinal Vasculitis After Syfovre Injections: Etiology is Still Unknown and Incidence Rate Remains Unclear
(Posted by Tom Lamb at Drug Injury Watch)
Syfovre (pegcetacoplan) was approved by the FDA in February 2023 as an eye injection to…
Syfovre Case Report: Occlusive Retinal Vasculitis Shortly After Patient’s First Syfovre Injection
By Tom Lamb
Pre-Existing Allergy Toward Polyethylene Glycol (PEG) is Most Recent Causation Theory Offered by Apellis
(Posted by Tom Lamb at Drug Injury Watch)
In late January 2024, a leading medical journal for ophthalmologists and retina specialists, the Journal…
"New" Blood Clots Side Effect of Semaglutide Weight Loss Drugs Like Ozempic: Deep Vein Thrombosis
By Tom Lamb
Research Finding: Semaglutide Increased the Risk of Deep Vein Thrombosis (DVT) by 266% in Patients with Type 2 Diabetes
(Posted by Tom Lamb at Drug Injury Watch)
Semaglutide-containing drugs that are being used for weight loss purposes…
Gastroparesis Case Reports Involving the Use of GLP-1 Receptor Agonists Semaglutide and Dulaglutide
By Tom Lamb
Learn About Related Symptoms and Diagnosis Process for Gastroparesis, a Side Effect of Ozempic, Wegovy, Rybelsus, and Trulicity
(Posted by Tom Lamb at Drug Injury Watch)
In this article, we present some gastroparesis case reports involving the…
Prolia Increased Risk Of Hypocalcemia In Patients With Chronic Kidney Disease (CKD) Can Be 20-Times Higher Than Pills
By Tom Lamb
Prolia “Black Box” Warning: Harm From Severe Hypocalcemia Ranges From Hospitalization For Life-threatening Events To Death
(Posted by Tom Lamb at Drug Injury Watch)
A January 2024 JAMA Original Investigation article, “Severe Hypocalcemia With Denosumab Among…
Syfovre Safety Issues Need More Attention Before This Relatively New Eye Drug Gets Widely Prescribed
By Tom Lamb
December 2023 JAMA Ophthalmology Viewpoint Piece About Syfovre Calls for Independent and Unbiased Evaluation
(Posted by Tom Lamb at Drug Injury Watch)
UPDATE: From this February 28, 2024, Fierce Pharma news report, “Apellis cites current challenges with Syfovre…
Syfovre Update: New Warnings About Retinal Vasculitis and/or Retinal Vascular Occlusion After Syfovre Injections
By Tom Lamb
November 2023 Syfovre Label Change Comes After Earlier Reports of Eye Inflammation and Severe Vision Loss
(Posted by Tom Lamb at Drug Injury Watch)
UPDATE: From this February 28, 2024, Fierce Pharma news report, “Apellis cites current…
Syfovre Patients Eye Side Effects Cases at Iowa Clinic: Important 2023 AAO Meeting Presentation
By Tom Lamb
A Syfovre Case of Hemorrhagic Occlusive Vasculitis-type Inflammation With Continued Blindness Is Reported
(Posted by Tom Lamb at Drug Injury Watch)
UPDATE: From this February 28, 2024, Fierce Pharma news report, “Apellis cites current challenges with Syfovre…